Multifunctional Radical Quenchers for Mitochondrial Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for mitochondrial disorders associated with decreased ATP production and oxidative stress, such as Friedreich's ataxia, Leber's Hereditary Optic Neuropathy, and Kearns-Sayre Syndrome, lack effective therapeutic agents that can mitigate mitochondrial dysfunction and oxidative damage.
Innovation Solution
Development of novel multifunctional radical quenching compounds, represented by formula (I), which are administered to treat or suppress diseases by reducing oxidative stress and enhancing mitochondrial function, thereby addressing diminished ATP production and lipid peroxidation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for mitochondrial disorders, then current standard care is maintained, but effective therapeutic agents to mitigate mitochondrial dysfunction and oxidative damage are lacking
Solution Approach 1:
The patent applies universality by designing a class of compounds (formula I) that can treat multiple mitochondrial disorders through a common mechanism. The compounds serve multiple functions: they quench radicals, scavenge reactive oxygen species, and protect mitochondrial membranes, making them effective across different disease states including Friedreich's ataxia, Leber's Hereditary Optic Neuropathy, and other mitochondrial cytopathies.
Solution Approach 2:
The patent utilizes parameter changes by modifying molecular structures (changing R1-R6 substituents, n values, and X groups) to optimize the compounds' antioxidant and radical-quenching properties. These structural parameter variations allow the same basic compound class to effectively address different mitochondrial disorders with varying severity and specific pathologies.
2Use of energy by moving object
If mitochondrial function is decreased leading to diminished ATP production, then energy deficiency occurs, but oxidative stress and lipid peroxidation increase causing further damage
Solution Approach 1:
The patent converts the harmful oxidative stress and radical production into beneficial effects by using the compounds to quench radicals and scavenge reactive oxygen species. The same mitochondrial processes that produce ATP also generate radicals; the compounds harness this by providing radical-quenching mechanisms that protect against the harmful effects while preserving the useful energy production function.
Solution Approach 2:
The compounds act as intermediary agents between the mitochondrial electron transport chain and the cell's antioxidant defense systems. They mediate the interaction by directly interacting with radicals and reactive oxygen species generated during ATP production, transferring the burden of oxidative damage management from the cell's existing defense systems to the therapeutic compounds.
3Object-affected harmful factors
If radical quenching compounds are developed to treat mitochondrial disorders, then oxidative stress is reduced, but the compounds must be effective across multiple disease states and conditions
Solution Approach 1:
The patent achieves universality by creating a broad class of radical quenching compounds that can address multiple disease states through a common mechanism. The compounds are designed to be effective across mitochondrial disorders, aging-related conditions, cancer, and other diseases with oxidative stress components, making them universally applicable therapeutic agents.
Solution Approach 2:
The patent employs parameter changes by systematically varying molecular parameters (substituents R1-R6, chain lengths, functional groups) to create a family of compounds with optimized properties for broad-spectrum efficacy. These parameter variations allow the same basic structure to effectively treat different diseases while maintaining consistent radical-quenching and antioxidant activities.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds effectively protect mitochondria and cells from oxidative stress, slowing disease progression and improving energy production in mitochondrial disorders, including Friedreich's ataxia, Leber's Hereditary Optic Neuropathy, and other conditions like obesity, cancer, and Alzheimer's Disease.
Implementation Method 1
Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
Implementation Method 2
reducing oxidative stress and enhancing mitochondrial function
Implementation Method 3
diminished ATP production and/or oxidative stress and/or lipid peroxidation
Data Source
AI summary
The present disclosure provides compounds of formula (I):compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased mitochondrial function resulting in diminished ATP production and/or oxidative stress and/or lipid peroxidation.